Optimising Radium 223 Therapy for Metastatic Castration-Resistant Prostate Cancer –5-year Real-World Outcome: Focusing on Treatment Sequence and Quality of Life

Autor: Jiang, X.Y. ^∗, Atkinson, S. ^†, Pearson, R. ^‡, Leaning, D. ^§, Cumming, S. ^∗, Burns, A. ^¶, Azzabi, A. ^∗, Frew, J. ^∗, McMenemin, R. ^∗, Pedley, I.D. ^∗

Publikováno v: In Clinical Oncology October 2020 32(10):e177-e187

SOCCAR: A randomised phase II trial comparing sequential versus concurrent chemotherapy and radical hypofractionated radiotherapy in patients with inoperable stage III Non-Small Cell Lung Cancer and good performance status

Autor: Maguire, J., Khan, I., McMenemin, R., O’Rourke, N., McNee, S., Kelly, V., Peedell, C., Snee, M.

Publikováno v: In European Journal of Cancer November 2014 50(17):2939-2949

Bone Health Management in Advanced Prostate Cancer: a Survey of UK Genitourinary Healthcare Professionals (GU HCPs)

Autor: Navarro-Rodriguez, C., Manoharan, D., McMenemin, R., Pearson, R., Birtle, A., Payne, H., Jiang, X.Y.

Publikováno v: In Clinical Oncology January 2024 36(1):e79-e79

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial.

Autor: Brown JE; Department of Oncology and Metabolism, University of Sheffield, Weston Park Hospital, Sheffield. Electronic address: j.e.brown@sheffield.ac.uk., Royle KL; Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Gregory W; Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Ralph C; Leeds Institute of Medical Research at St James's, Leeds Institute for Medical Research, University of Leeds, Leeds, UK., Maraveyas A; Queens Centre for Oncology and Haematology, Faculty of Health Sciences, Hull York Medical School, Hull, UK., Din O; Department of Clinical Oncology, Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Eisen T; Department of Oncology, University of Cambridge, Cambridge, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Nathan P; Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, Northwood, UK., Powles T; Barts Cancer Institute, Queen Mary University, London, UK., Griffiths R; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK., Jones R; University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK., Vasudev N; Leeds Institute of Medical Research at St James's, Leeds Institute for Medical Research, University of Leeds, Leeds, UK., Wheater M; University Hospital Southampton NHS Foundation Trust, Southampton, UK., Hamid A; Broomfield Hospital, Mid and South Essex NHS Foundation Trust, Chelmsford, UK., Waddell T; Christie NHS Foundation Trust, Manchester, UK., McMenemin R; Northern Centre for Cancer Care, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK., Patel P; Academic Unit of Translational Medical Sciences, University of Nottingham, Nottingham, UK., Larkin J; Royal Marsden NHS Foundation Trust, London, UK., Faust G; Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, UK., Martin A; Academic Unit of Health Economics, Leeds Institute for Medical Research, University of Leeds, Leeds, UK., Swain J; Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Bestall J; Leeds Institute of Health Sciences, Leeds Institute for Medical Research, University of Leeds, Leeds, UK., McCabe C; Centre for Public Health, Queens University, Belfast, UK., Meads D; Academic Unit of Health Economics, Leeds Institute for Medical Research, University of Leeds, Leeds, UK., Goh V; School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK., Min Wah T; Department of Radiology, Leeds Institute for Medical Research, University of Leeds, Leeds, UK., Brown J; Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Hewison J; Leeds Institute of Health Sciences, Leeds Institute for Medical Research, University of Leeds, Leeds, UK., Selby P; Leeds Institute of Medical Research at St James's, Leeds Institute for Medical Research, University of Leeds, Leeds, UK., Collinson F; Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2023 Mar; Vol. 24 (3), pp. 213-227. Date of Electronic Publication: 2023 Feb 13.